Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds
- Posted: April 25, 2013
When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive, potentially life-threatening course than in other children, probably because of delays in diagnosis, researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) in Boston are reporting at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami, April 24-27.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.